Page last updated: 2024-08-24

1,2-dipalmitoylphosphatidylglycerol and Carcinoma, Epidermoid

1,2-dipalmitoylphosphatidylglycerol has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulikas, T; Darli, E; Deliconstantinos, G; Rigatos, S; Stathopoulos, GP; Stathopoulos, JG; Viliotou, V; Vougiouka, M1

Trials

1 trial(s) available for 1,2-dipalmitoylphosphatidylglycerol and Carcinoma, Epidermoid

ArticleYear
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
    Oncology reports, 2005, Volume: 13, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Carcinoma, Squamous Cell; Cholesterol; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Kinetics; Lipids; Liposomes; Male; Middle Aged; Nanotechnology; Pancreatic Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Stomach Neoplasms; Time Factors

2005